NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 137 filers reported holding NEKTAR THERAPEUTICS in Q3 2023. The put-call ratio across all filers is 5.78 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $4,000 | -20.0% | 218 | 0.0% | 0.00% | – |
| Q2 2020 | $5,000 | -99.6% | 218 | -99.6% | 0.00% | -100.0% |
| Q3 2019 | $1,120,000 | -56.0% | 61,467 | -14.2% | 0.00% | 0.0% |
| Q2 2019 | $2,547,000 | -23.4% | 71,604 | -27.7% | 0.00% | -60.0% |
| Q1 2019 | $3,325,000 | -64.8% | 98,991 | -65.6% | 0.01% | -44.4% |
| Q4 2018 | $9,455,000 | -46.1% | 287,663 | -0.0% | 0.01% | -60.9% |
| Q3 2018 | $17,538,000 | +27.6% | 287,704 | +2.2% | 0.02% | +15.0% |
| Q2 2018 | $13,747,000 | -25.1% | 281,528 | +63.0% | 0.02% | -31.0% |
| Q1 2018 | $18,350,000 | +62.5% | 172,684 | -8.7% | 0.03% | +70.6% |
| Q4 2017 | $11,293,000 | – | 189,100 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 1,828,400 | $89,281,000 | 6.61% |
| Cormorant Asset Management, LP | 1,500,000 | $73,245,000 | 5.42% |
| Camber Capital Management LP | 2,000,000 | $97,660,000 | 3.76% |
| Rhenman & Partners Asset Management AB | 617,652 | $30,160,000 | 3.09% |
| BRIDGER MANAGEMENT, LLC | 1,134,414 | $55,393,000 | 3.00% |
| First Light Asset Management, LLC | 374,251 | $18,275,000 | 2.84% |
| Gs Investments, Inc. | 54,000 | $2,636,820,000 | 1.97% |
| SABBY MANAGEMENT, LLC | 241,922 | $11,813,000 | 1.82% |
| QUANTRES ASSET MANAGEMENT Ltd | 50,000 | $2,441,000 | 1.41% |
| Tibra Equities Europe Ltd | 173,183 | $8,457,000 | 1.27% |